The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
FDA approves Wegovy to lower risk for CVD events in patients with obesity
Mar 08, 2024
Agency’s action could widen access to the drug if more insurance companies decide to cover it
ESC: Adverse outcomes increased with suboptimal adherence to aspirin after MI
Aug 28, 2023
The risk increased for recurrent MI, ischemic stroke or death with suboptimal adherence through eight years after MI.
Million hearts model cuts five-year heart attack, stroke risk in at-risk patients
Oct 18, 2023
Improved outcomes were seen, with no significant changes in Medicare spending.
American Stroke Association, Feb. 7-9
Feb 20, 2024
The conference featured presentations that emphasized basic, clinical and translational medicine and provided insight into the prevention, management and treatment of stroke.